Trial Profile
A proof-of-concept phase IIa study of VBY-036 for the treatment of chronic chemotherapy-induced peripheral neuropathy
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2016
Price :
$35
*
At a glance
- Drugs VBY 036 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- 05 Apr 2016 New trial record